Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by educational grants from Dova Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation.

Advances In™ Idiopathic Thrombocytopenic Purpura: Exploring the Latest Findings in Treatment and Management

Release Date: July 30, 2021
Expiration Date: July 30, 2022

Activity Overview

This activity provides an overview of recent data on emerging options for the treatment of idiopathic thrombocytopenic purpura (ITP). Experts discuss the latest results for the novel thrombopoietin receptor agonists, including long-term follow-up data. Topics also include considerations for making treatment decisions and meeting patient needs for optimizing outcomes. You will benefit from expert opinion on how and when to incorporate new options into your treatment strategy for your patients.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Dova Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

These activities are directed toward hematologists, hematology-oncologists, pathologists, and other oncology health care professionals interested in the latest advances in the treatment of patients with idiopathic thrombocytopenia purpura (ITP). Fellows, researchers, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the treatment of patients with ITP are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Develop effective strategies and standards for diagnosing ITP and determining which patients may benefit from treatment
  • Assess efficacy and safety of currently approved therapies in the management of patients with ITP
  • Integrate recent advances in treatments as well as guideline-based recommendations to personalize care for patients with ITP in various settings
  • Evaluate updated and emerging data for current and investigational therapies within the context of evolving treatment strategies for ITP treatment

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Faculty

Craig M. Kessler, MD
Craig M. Kessler, MD
Professor of Medicine and Pathology
Director, Division of Coagulation
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington, DC

Disclosures: Grant/Research Support: Octapharma, Takeda Pharmaceutical Co; Consultant: CSL Behring, Octapharma, Takeda Pharmaceutical Co; Other Support: Director, 340B Program at Hemophilia Treatment Centers, Novartis Pharmaceuticals, Rigel Pharmaceuticals.

Ilene C. Weitz, MD
Ilene C. Weitz, MD
Professor of Clinical Medicine
Jane Anne Nohl Division of Hematology
Keck School of Medicine
University of Southern California
Los Angeles, CA

Disclosures: Dr. Ilene C. Weitz, MD, has no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
28293031
Filter By